Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Frisch, M.
space
  arrow  Melbye, M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Risk for Subsequent Cancer after Diagnosis of Basal-Cell Carcinoma: A Population-Based, Epidemiologic Study

right arrow Morten Frisch, MD, PhD; Henrik Hjalgrim, MD; Jorgen H. Olsen, MD, DMSc; and Mads Melbye, MD, DMSc

15 November 1996 | Volume 125 Issue 10 | Pages 815-821

Background: Considerable debate is taking place over whether patients with basal-cell carcinoma and other skin neoplasms are at increased risk for internal cancer.

Objective: To investigate risk for subsequent cancer in patients with basal-cell carcinoma.

Design: Population-based cohort study.

Setting: Denmark, from 1978 to 1991.

Patients: 37 674 patients followed for a maximum of 14 years after a first diagnosis of basal-cell carcinoma.

Measurements: The occurrence of subsequent cancer was compared with the expected cancer pattern (which was determined on the basis of national incidence data). Standardized incidence ratios (SIRs), ratios of actual to expected number of cases of cancer, yielded estimates of the relative risk.

Results: During 190 945 patient-years of follow-up, 3663 new cases of cancer occurred where only 3245 were expected. As anticipated, malignant melanoma occurred frequently (SIR, 2.64 [95% CI, 2.21 to 3.13]), but patients were also at increased risk for noncutaneous cancer (SIR, 1.19 [CI, 1.13 to 1.24] for men and 1.09 [CI, 1.03 to 1.16] for women). The excess risk for noncutaneous cancer pertained to cancer of the lip (SIR, 2.07), salivary glands (SIR, 2.45), larynx (SIR, 1.41), lung (SIR, 1.40), breast (SIR, 1.13), and kidney (SIR, 1.30) and non-Hodgkin lymphoma (SIR, 1.36). Patients receiving a diagnosis of basal-cell carcinoma before 60 years of age (SIR, 1.26) had a statistically higher risk for developing new cancer (P < 0.01) than did those receiving the diagnosis at 60 years of age or older (SIR, 1.11). This applied to breast cancer (SIR, 1.37 in patients <60 years of age compared with 1.05 in those ≥ 60 years of age), testicular cancer (SIR, 3.52 in patients <60 years of age compared with 0 seen and 1.96 expected in those ≥ 60 years of age), and non-Hodgkin lymphoma (SIR, 2.50 in patients <60 years of age compared with 1.16 in those ≥ 60 years of age).

Conclusion: In addition to having an increased risk for new skin cancer, patients with basal-cell carcinoma have an increased risk for noncutaneous cancer at various sites. Increased risks for testicular cancer, breast cancer, and non-Hodgkin lymphoma should be kept in mind, particularly for patients in whom basal-cell carcinoma is diagnosed when they are at a young age.

Author and Article Information
space

From Statens Seruminstitut and the Danish Cancer Society, Copenhagen, Denmark.
Acknowledgments: The authors thank Ms. Andrea Meersohn of the Danish Cancer Society for computer assistance.
Grant Support: By grant 94-100-17 from the Danish Cancer Society.
Requests for Reprints: Morten Frisch, MD, PhD, Danish Epidemiology Science Centre, Statens Seruminstitut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.
Current Author Addresses: Drs. Frisch, Hjalgrim, and Melbye: Danish Epidemiology Science Centre, Statens Seruminstitut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.


Related articles in Annals:

Editorials
Basal-Cell Carcinoma of the Skin: A Harbinger of Cutaneous and Noncutaneous Multiple Primary Cancer
David Schottenfeld
Annals 1996 125: 852-854. [Full Text]  



This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
J. Chen, I. Ruczinski, T. J. Jorgensen, G. Yenokyan, Y. Yao, R. Alani, N. J. Liegeois, S. C. Hoffman, J. Hoffman-Bolton, P. T. Strickland, et al.
Nonmelanoma Skin Cancer and Risk for Subsequent Malignancy
J Natl Cancer Inst, September 3, 2008; 100(17): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E Theander, G Henriksson, O Ljungberg, T Mandl, R Manthorpe, and L T H Jacobsson
Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors
Ann Rheum Dis, June 1, 2006; 65(6): 796 - 803.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Nugent, A. A. Demers, M. C. Wiseman, C. Mihalcioiu, and E. V. Kliewer
Risk of Second Primary Cancer and Death Following a Diagnosis of Nonmelanoma Skin Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2584 - 2590.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. T. Chang, K. E. Smedby, H. Hjalgrim, A. Porwit-MacDonald, G. Roos, B. Glimelius, and H.-O. Adami
Family History of Hematopoietic Malignancy and Risk of Lymphoma
J Natl Cancer Inst, October 5, 2005; 97(19): 1466 - 1474.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. E. Smedby, H. Hjalgrim, M. Melbye, A. Torrang, K. Rostgaard, L. Munksgaard, J. Adami, M. Hansen, A. Porwit-MacDonald, B. A. Jensen, et al.
Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas
J Natl Cancer Inst, February 2, 2005; 97(3): 199 - 209.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, S. H. Zahm, P. H. Owens, L. M. Morton, B. Zhang, K. Zou, S. Flynn, et al.
Blood Transfusion and Risk of Non-Hodgkin's Lymphoma in Connecticut Women
Am. J. Epidemiol., August 15, 2004; 160(4): 325 - 330.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Brewster, A. J. Alberg, P. T. Strickland, S. C. Hoffman, and K. Helzlsouer
XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1271 - 1275.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C S M Wong, R C Strange, and J T Lear
Basal cell carcinoma
BMJ, October 4, 2003; 327(7418): 794 - 798.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
B. A. Nexo, U. Vogel, A. Olsen, T. Ketelsen, Z. Bukowy, B. L. Thomsen, H. Wallin, K. Overvad, and A. Tjonneland
A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55
Carcinogenesis, May 1, 2003; 24(5): 899 - 904.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. MOLLER, H. WALLIN, E. HOLST, and L. E. KNUDSEN
Sunlight-induced DNA damage in human mononuclear cells
FASEB J, January 1, 2002; 16(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
I. Marcil and R. S. Stern
Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer: A Critical Review of the Literature and Meta-analysis
Arch Dermatol, December 1, 2000; 136(12): 1524 - 1530.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Askling, P. Sorensen, A. Ekbom, M. Frisch, M. Melbye, B. Glimelius, and H. Hjalgrim
Is History of Squamous-Cell Skin Cancer a Marker of Poor Prognosis in Patients with Cancer?
Ann Intern Med, November 2, 1999; 131(9): 655 - 659.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. Bonnerup Jaeger, A. Gramkow, H. Hjalgrim, M. Melbye, and M. Frisch
Bowen Disease and Risk of Subsequent Malignant Neoplasms: A Population-Based Cohort Study of 1147 Patients
Arch Dermatol, July 1, 1999; 135(7): 790 - 793.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D’Errico, A. Calcagnile, I. Iavarone, F. Sera, G. Baliva, L. M. Chinni, R. Corona, P. Pasquini, and E. Dogliotti
Factors That Influence the DNA Repair Capacity of Normal and Skin Cancer-affected Individuals
Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 553 - 559.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
M. Frisch, H. Hjalgrim, F. Levi, L. Randimbison, and C. La Vecchia
Re: Nonmelanomatous Skin Cancer Following Cervical, Vaginal, and Vulvar Neoplasms: Etiologic Association • RESPONSE
J Natl Cancer Inst, March 17, 1999; 91(6): 565 - 566.
[Full Text] [PDF]


Home page
JAMAHome page
J. S. Spratt Jr, H. S. Kahn, and M. J. Thun
Cancer Mortality After Nonmelanoma Skin Cancer
JAMA, January 27, 1999; 281(4): 325 - 325.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
P. Meier, I. Sterker, and T. Meier
Primary Basal Cell Carcinoma of the Caruncle
Arch Ophthalmol, October 1, 1998; 116(10): 1373 - 1374.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. S. Kahn, L. M. Tatham, A. V. Patel, M. J. Thun, and C. W. Heath Jr
Increased Cancer Mortality Following a History of Nonmelanoma Skin Cancer
JAMA, September 9, 1998; 280(10): 910 - 912.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch DermatologyHome page
Risk of Internal Cancer after Diagnosis of BCC
Journal Watch Dermatology, March 1, 1997; 1997(301): 10 - 10.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1996 by the American College of Physicians.